Sangamo, Novartis Make Gene Therapy Deal for Brain Disorders

(Bloomberg) -- Small-cap drug developer Sangamo Therapeutics Inc. jumped after striking a deal with Novartis AG to develop gene therapies for disorders attacking the brain and central nervous syste...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.